Use of serum calprotectin as rutine biomarker of bacterial infection
Authors:
S. Arientová 1; L. Pospíšilová 2; M. Blahutová 2; M. Holub 1
Authors‘ workplace:
Ústřední vojenská nemocnice, Klinika infekčních nemocí 1. LF UK a ÚVN
1; Ústřední vojenská nemocnice, Oddělení klinické biochemie ÚVN
2
Published in:
Klin. Biochem. Metab., 29, 2021, No. 4, p. 204-208
Overview
Objective: evaluation of clinical use of serum calprotectin as biomarker of bacterial infection
Design: prospective, observational study
Settings: Military University Hospital Prague
Material and Methods: all patients admitted to the Department of infectious Diseases during the period between January and March 2020 were enrolled to the study. Serum calprotectin was analyzed using EVOLIS™ Microplate system and commercially available assay from the Biovendor company.
Results: Altogether, data of 36 enrolled patients with proven bacterial or viral infection (24 males and 12 females with mean age 63.9 years) were evaluated. The most frequent source of bacterial infection was respiratory tract (33.3 %) followed by soft tissue (25 %) and infections of urogenital and gastrointestinal tracts (both 16.7 %). The most common viral infection was flu A (66.6 %). Median of calprotectin serum concentration in bacterial infection was 4.12 mg/L in comparison to 2.03 mg/L in viral infection. In 12 patients with bacterial infection with negative procalcitonin (PCT) levels, both C-reactive protein (CRP) and calprotectin were elevated. On the other hand, eight patients with proven bacterial infection had negative calprotectin serum levels. Four of these patients had elevated CRP and PCT and four CRP only. In addition, in the cohort with bacterial infection, there was one patient with calprotectin elevation only.
Conclusion: the results of our study indicated serum calprotectin as additional parameter of bacterial infection.
Keywords:
biomarker – bacterial infection – serum calprotectin
Sources
1. Saïd-Sadier, N., Ojcius, D. M. Alarmins, inflammasomes and immunity. Biomed. J., 2012, 35, 6, s. 437 - 449.
2. Decembrino, L., De Amici, M., Pozzi, M., De Silvestri, A., Stronati, M. Serum Calprotectin: A Potential Biomarker for Neonatal Sepsis. J. Immunol. Res., 2015, 2015, 147973.
3. Máca, J., Burša, F., Ševčík, P., Sklienka, P., Burda, M., Holub, M. Alarmins and clinical outcomes after major abdominal surgery - a prospective study. J. Invest. Surg., 2017, 30, s. 152 - 161.
4. Hurňaková, J., Hulejova, H., Závada, J., Komarc, M., Cerezo, LA., Mann, H., Vencovský, J., Pavelka, K., Šenolt, L. Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. Clin. Rheumatol., 2018, 37, 8, s. 2055 - 2062.
5. Topuz, M. F., Binnetoglu, A., Yumusakhuylu, A. C., Sarı, M., Baglam, T., Gerin, F. Circulating calprotectin as a biomarker of laryngeal carcinoma. Eur. Arch. Otorhinolaryngol., 2017, 274, 6, s. 2499 - 2504.
6. Holub, M., Bartáková, E., Stráníková, A., Koblihová, E., Arientová, S., Blahutová, M., Máca, J., Ryska, M. Calprote tin and Calgranulin C as Biomarkers of Pancreatic Tumors: Baseline Levels and Level Changes after Surgery. Mediators. Inflamm., 2019, 2019, s. 6985703.
7. Chan, J. K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N., Nanchahal, J. Alarmins: awaiting a clinical response. J. Clin. Invest., 2012, 122, 8, s. 2711 - 2719.
8. Kim, M. H., Choi, J. H. An Update on Sepsis Biomarkers. Infect. Chemother., 2020, 52, 1, s. 1 - 18.
9. Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J. C., Vincent, J. L. Biomarkers of sepsis: time for a reappraisal. Crit. Care., 2020, 24, 1, s. 287.
10. Yang, Y., Liu, G., He, Q., Shen, J., Xu, L., Zhu, P., Zhao, M. A Promising Candidate: Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction. J. Immunol. Res., 2019, 2019, s. 7515346.
11. Memar, M. Y., Baghi, H. B. Presepsin: A promising biomarker for the detection of bacterial infections. Biomed. Pharmacother., 2019, 111, s. 649 - 656.
12. Bartaková, E., Štefan, M., Stráníková, A., Pospíšilová, L., Arientová, S., Beran, O., Blahutová, M., Máca, J., Holub, M. Calprotectin and calgranulin C serum levels in bacterial sepsis. Diagn. Microbiol. Infect. Dis., 2019, 93, 3, s. 219 - 226.
13. Mierzchała-Pasierb, M., Lipińska-Gediga, M. Sepsis diagnosis and monitoring - procalcitonin as standard, but what next? Anaesthesiol. Intensive. Ther., 2019, 51, 4, s. 299 - 305.
14. Bartáková, E., Novotný, P., Blahutová, M., Holub, M., Tyll, T. Alarminy u polytraumatizovaných pacientů. Anest. Intenziv. Med., 2018, 29, 4, s. 193 - 200.
15. Nilsen, T., Sunde, K., Larsson, A. A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers. J. Inflamm., 2015, 12, s. 45.
16. Åsberg, A., Løfblad, L., Felic, A., Hov, GG. Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay. Scand. J. Clin. Lab. Invest., 2019, 79, 1-2, s. 50 - 57.
17. Jonsson, N., Nilsen, T., Gille-Johnson, P., Bell, M., Martling, C. R., Larsson, A., Mårtensson, J. Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment. Crit. Care. Resusc., 2017, 19, č.3, s. 205 - 213.
18. Havelka, A., Sejersen, K., Venge, P., Pauksens, K., Larsson, A. Calprotectin, a new biomarker for diagnosis of acute respiratory infections. Sci. Rep., 2020, 10, 1, s. 4208.
19. Xu, D., Li, Y., Li, X., Wei, L. L., Pan, Z., Jiang, T. T. et al. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteonomics., 2015, 15, s. 58 - 67.
20. Natesan, M., Corea, E., Krishnananthasivam, S., Sathkumara, H. D., Dankmeyer, J. L., Dyas, B. K., Amemiya, K., De Silva, A. D., Ulrich, R. G. Calprotectin as a Biomarker for Melioidosis Disease Progression and Management. J. Clin. Microbiol., 2017, 55, 4, s.1205 – 1210.
21. Bauer, W., Diehl-Wiesenecker, E., Ulke, J., Galtung, N., Havelka, A., Hegel, J. K., Tauber, R., Somasundaram, R., Kappert, K. Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department. J. Infect., 2021, 82, 4, s. 84 - 123.
Labels
Clinical biochemistry Nuclear medicine Nutritive therapistArticle was published in
Clinical Biochemistry and Metabolism
2021 Issue 4
Most read in this issue
- Use of serum calprotectin as rutine biomarker of bacterial infection
- Urea cycle disorders, Arginine Chloride in the treatment of hyperammonemia
- Monoklonální gamapatie – stále aktuální téma
- Pleural effusion – cytological-energy analysis versus traditional Light’s criteria